Qube Research & Technologies (QRT)
BBOT icon

Qube Research & Technologies (QRT)’s BridgeBio Oncology BBOT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71,925
Closed -$644K – 4199
2026
Q1 		$644K Buy
71,925
+35,973
+100% +$386K ﹤0.01% 2656
2025
Q4 		$450K Buy
+35,952
New +$436K ﹤0.01% 2830

Other funds holding BBOT

Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Omega Fund Management
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Enavate Sciences
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Novo Holdings A/S
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 107.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BBOT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of BridgeBio Oncology (BBOT) in Q2 2026, closing a stake of 71,925 shares — an estimated $644K sold.

Qube Research & Technologies (QRT) first reported a position in BBOT in Q4 2025 and held it in 2 quarters. The position peaked at $644K in Q1 2026. 65 funds tracked by Wall St. Rank hold BBOT as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining BridgeBio Oncology position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 71,925 BridgeBio Oncology shares in Q2 2026, an estimated $644K.
  • Qube Research & Technologies (QRT) first reported a position in BridgeBio Oncology in Q4 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s BridgeBio Oncology position peaked at $644K in Q1 2026.
  • 65 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.